MedWatch

Sanofi launches insulin pen in India

The Novo Nordisk rival Sanofi is launching a new insulin pen through their Indian division, and says the product has the potential to be exported to other markets.

Foto: Manish Swarup

This Tuesday Sanofi introduced the insulin pen Allstar on the Indian market. The pen is recyclable and according to the Danish financial information bureau Aktiefokus, it sees Sanofi increasing its efforts on a market currently dominated by Novo Nordisk.

But India is not the end destination of the new pen. According to Reuters CEO of Sanofi India, Shailesh Ayyangar, the company is also planning to export the pen to countries in Southeast Asia, South Africa and Latin America.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier